Cargando…
Liposomes and nanotechnology in drug development: focus on neurological targets
Neurological diseases represent a medical, social, and economic problem of paramount importance in developed countries. Although their etiology is generally known, developing therapeutic interventions for the central nervous system is challenging due to the impermeability of the blood–brain barrier....
Autores principales: | Ramos-Cabrer, Pedro, Campos, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3592553/ https://www.ncbi.nlm.nih.gov/pubmed/23486739 http://dx.doi.org/10.2147/IJN.S30721 |
Ejemplares similares
-
Liposomes and nanotechnology in drug development: focus on ocular targets
por: Honda, Miki, et al.
Publicado: (2013) -
Liposomes and nanotechnology in drug development: focus on oncotargets
por: Kozako, Tomohiro, et al.
Publicado: (2012) -
Application of liposomes in drug development — focus on gastroenterological targets
por: Zhang, Jian-Xin, et al.
Publicado: (2013) -
Targeted therapy using nanotechnology: focus on cancer
por: Sanna, Vanna, et al.
Publicado: (2014) -
Strategic use of nanotechnology in drug targeting and its consequences on human health: A focused review
por: Maurya, Anand, et al.
Publicado: (2019)